Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisArun J. Sanyal, Patricia R. Robuck, Jay H. Hoofnagle et al.|New England Journal of Medicine|2010Cited by 3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander‐Tetri, Edward Doo, Rohit Loomba et al.|The Lancet|2014Cited by 2.2k
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic ConferenceBrent A. Neuschwander‐Tetri, Stephen H. Caldwell|Hepatology|2003Cited by 2.1k
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitisBrent A. Neuschwander‐Tetri|Hepatology|2010Cited by 1.1k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver DiseaseArun J. Sanyal, James Tonascia, Mark L. Van Natta et al.|New England Journal of Medicine|2021Cited by 1.1k